Paroxysmal atrial fibrillation prevention by pacing in patients with pacemaker indication

Europace

Volumn 5, Issue 3, 2003, Pages 267-273

  Lozano, Ignacio Fernández ^a   Vincent, A ^h   Roda, J ^b   Mendez M ^c   Ferrer, J M M ^d   Andrade, F ^e   Manzano, J J ^f   Ceres, R ^g   Errejon, J ^g   Toquero, J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^d HOSPITAL TXAGORRITXU   (Spain)

^e Hospital General del Insalud Soria   (Spain)

^f HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^h NONE

Author keywords

Atrial fibrillation; Atrial fibrillation burden; Electrical stimulation; Pacemaker; Pacing algorithms; Sick sinus syndrome

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGE; AGED; ALGORITHM; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SEX RATIO; SICK SINUS SYNDROME; SPAIN; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; REGISTRIES; SICK SINUS SYNDROME;

EID: 0042668323     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1099-5129(03)00041-2     Document Type: Article

References (30)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-22.
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155: 469-73.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998: 98: 946-52.
4. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta analysis of randomized controlled trials. Circulation 1990; 82: 1106-16.
5. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992; 117: 141-50.
6. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation: an evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994; 48: 345-71.
7. Ganz LI, Antman EM. Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol 1997; 8: 1175-89.
8. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B. The Canadian trial of atrial fibrillation investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000; 342: 913-20.
9. Cox JL, Schuessler RB, D'Agostino HJ, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991; 101: 569-83.
10. Jaïs P, Haïssaguerre M, Shah DC, et al, A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6.
11. Friedman PA, Dijkman B, Warman EN, et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001; 104: 1023-8.
12. Israel CW, Lawo T, Lemke B, Gronefeld G, Hohnloser SH. Atrial pacing in prevention of paroxysmal atrial fibrillation: first results of a new combined algorithm. Pacing Clin Electrophysiol 2000; 23: 1888-90.
13. Ricci R, Santini M, Puglisi A, Azzolini P, Capucci A, Pignalberi C, Boriani G, Botto GL, Spampinato A, Bellocci F, Proclemer A, Grammatico A, de Seta F. Impact of consistent atrial pacing algorithm on premature atrial com number paroxysmal atrial fibrillation recurrences in bradytachy syndrome: a randomized prospective crossover study. J Interv Card Electrophysiol 2001; 5: 33-44.
14. Israel CW, Hugl B, Unterberg C, et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12: 1121-8.
15. Andersen HR, Nielsen JC, Thomsen PEB, et al, Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997; 350: 1210-6.
16. Skanes AC, Krahn A, Yee R, et al. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. CTOPP investigators. J Am Coll Cardiol 2001; 38: 167-72.
17. Lamas GA, Lee K, Sweeney M, et al. MOST investigators. The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 2000; 140: 541-51.
18. Daubert C, Mabo P, Berder V. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronization. Eur J Card Pacing Electrophysiol 1994; 4: 35-44.
19. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996; 28: 687-94.
20. Prakash A, Saksena S, Krol R. Dual site pacing is effective for atrial fibrillation prevention in patients with and without conduction delay (Abstr Suppl). JACC 2001; 37: 95A.
21. Ip J, Beau S, Cameron D, Messenger J. Early results of Adopt A. A dynamic atrial overdrive pacing to treat paroxysmal atrial fibrillation (Abstract). Pacing Clin Electrophysiol 2001; 24: 306.
22. Israel CW, Hugl B, Unterberg C, et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12: 1121-8.
23. Camm J. The atrial fibrillation therapy study. XXIII European Congress of Cardiology. [Presentation]. Stockholm 1-5 September 2001.
24. Camm J. AF therapy study: preventive pacing for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2002; 24. (Abstract).
25. Camm AJ. AF therapy study: preventive pacing for paroxysmal atrial fibrillation. Europace 2002; 3(Suppl. A206). (Abstract).
26. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88: 1045-53.
27. Rosenquist M, Brandt J, Schüller H. Long term pacing in sinus node disease. Effect of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22.
28. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and mode of permanent cardiac pacing. Am J Cardiol 1990; 65: 729-35.
29. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 1998; 97: 1325-35.
30. Nowak B, Kracker S, Rippin G. Effect of atrial blanking time on the detection of atrial fibrillation in dual chamber pacing. Pacing Clin Electrophysiol 2001; 24: 496-9.